ERBB2 and neoplasm: On the one hand, it might be assumed that tumor cells which have left the tumor might experience phenotypic and genetic differentiation during circulation, enabling them to turn from, e.g. HER2-neg on the PT to HER2-pos on single tumor cells and/or metastases and vice versa.